Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Nov 2023 for Sprint Bioscience AB, €3,673.
Filing timeline
BuySaleOT Pharmaceuticals AB
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
OT Pharmaceuticals AB: trading record in brief
One trade, one date: on 24 November 2023, OT Pharmaceuticals AB disclosed an open-market purchase of €3,673 in Sprint Bioscience AB. No broader history exists yet. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to OT Pharmaceuticals AB
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 20,000 shares@ SEK 2.10100.0% of flowAktieISIN SE0006343745FI:csv-93c6a22fb16aca368f45Canonical exit: 19 Feb 2024 (T+90)
1 of 1 declaration